Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis

Infection and Immunity

Volumn 66, Issue 5, 1998, Pages 2135-2142

  Melby, Peter C ^a,b   Tryon, Victor V ^a   Chandrasekar, Bysani ^b   Freeman, Gregory L ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; IMMUNOPATHOGENESIS; INFECTION SENSITIVITY; LEISHMANIA; MACROPHAGE ACTIVATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SYRIAN HAMSTER; VISCERAL LEISHMANIASIS;

EID: 0031948654     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.5.2135-2142.1998     Document Type: Article

References (63)

1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Assoian, R. K., B. E. Fleurdelys, H. C. Stevenson, P. J. Miller, D. K. Madtes, E. W. Raines, R. Ross, and M. B. Sporn. 1987. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA 84:6020-6024.
3. Barral-Netto, M., A. Barral, C. E. Brownell, Y. A. W. Skeiky, L. R. Ellingsworth, D. R. Twardzik, and S. G. Reed. 1992. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science 257:545-548.
4. Chandrasekar, B., P. C. Melby, D. A. Troyer, and G. L. Freeman. 1996. Induction of proinflammatory cytokine expression in experimental acute chagasic cardiomyopathy. Biochem. Biophys. Res. Commun. 223:365-371.
5. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-154.
6. Collins, L., W.-H. Tsien, C. Seals, J. Hakimi, D. Weber, P. Bailon, J. Hoskings, W. C. Greene, V. Toome, and G. Ju. 1998. Identification of specific residues of human interleukin 2 that affect binding to the 70-kDa subunit (p70) of the interleukin 2 receptor. Proc. Natl. Acad. Sci. USA 85:7709-7713.
7. Del Prete, G., M. De Carli, F. Almerigogna, M. G. Guidizi, R. Biagiotti, and S. Romangnani. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353-360.
8. Derynck, R., J. A. Jarrett, E. Y. Chen, and D. V. Goeddel. 1986. The murine transforming growth factor-β precursor. J. Biol. Chem. 261:4377-4379.
9. Derynck, R., J. A. Jarrett, E. Y. Chen, D. H. Eaton, J. R. Bell, R. K. Assoian, A. B. Roberts, M. B. Sporn, and D. V. Goeddel. 1985. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705.
10. Dijkema, R., P. H. van der Meide, P. H. Pouwels, M. Caspers, M. Dubbeld, and H. Schellekens. 1985. Cloning and expression of the chromosomal immune Interferon gene of the rat. EMBO J. 4:761-767.
11. Ding, A., C. F. Nathan, J. Grayear, R. Derynck, D. J. Stuehr, and S. Srimal. 1990. Macrophage deactivating factor and transforming growth factors-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol. 145:940-944.
12. Estler, H. C., M. Grewe, R. Gaussling, M. Pavlovic, and K. Decker. 1992. Rat tumor necrosis factor-alpha. Transcription in rat Kupffer cells and in vitro posttranslational processing based on a PCR-derived cDNA. Biol. Chem. Hoppe-Seyler 373:271-281.
13. Frenkle, J. K. 1987. Experimental biology: use in infectious disease research, p. 227-249. In G. L. Van Hoosier and C. W. McPherson (ed.), Laboratory hamsters. Academic Press Inc., New York, N.Y.
14. Ghalib, H. W., M. R. Piuvezam, Y. A. W. Skeiky, M. Siddiq, F. A. Hashim, A. M. El-Hassan, D. M. Russo, and S. G. Reed. 1993. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92:324-329.
15. Gifawesen, C., and J. P. Farrell. 1989. Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters. Infect. Immun. 57:3091-3096.
16. Goodman, R. E., J. Oblak, and R. G. Bell. 1992. Synthesis and characterization of rat interleukin-10 (IL-10) cDNA clones from the RNA of cultured OX8-OX22-thoracic duct T cells. Biochem. Biophys. Res. Commun. 189: 1-7.
17. Gray, P. W., and D. V. Goeddel. 1983. Cloning and expression of murine immune interferon cDNA. Proc. Natl. Acad. Sci. USA 80:5842-5846.
18. Gray, P. W., D. W. Leung, D. Pennica, E. Yelverton, R. Najarian, C. C. Simonsen, R. Derynck, P. J. Sherwood, D. M. Wallace, S. L. Berger, A. D. Levinson, and D. V. Goeddel. 1982. Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 295:503-508.
19. Griggs, N. D., M. A. Jarpe, J. L. Pace, S. W. Russell, and H. M. Johnson. 1992. The N-terminus and C-terminus of IFN-γ are binding domains for cloned soluble IFN-γ receptor. J. Immunol. 149:517-520.
20. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon-γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for the expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
21. Holaday, B. J., M. M. de Lima Pompeu, S. Jeronimo, M. J. Texeira, A. de Queiroz Sousa, A. W. Vasconcelos, R. D. Pearson, J. S. Abrams, and R. M. Locksley. 1993. Potential role for interleukin-10 in the immunosuppression associated with kala azar. J. Clin. Invest. 92:2626-2632.
22. Jansen, J. G., H. Vrieling, A. A. van Zeeland, and G. R. Mohn. 1992. The gene encoding hypoxanthine-guanine phosphoribosyltransferase as a target for mutational analysis: PCR cloning and sequencing of the cDNA from the rat. Mutat. Res. 266:105-116.
23. Jolly, D. J., H. Okayama, P. Berg, A. C. Esty, D. Filpula, P. Bohlen, G. G. Johnson, J. E. Shively, T. Hunkapillar, and T. Friedman. 1983. Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA 80:477-481.
24. Ju, G., L. Collins, K. L. Kafka, W.-H. Tsien, R. Chizzonite, R. Crowl, R. Bhatt, and P. L. Kilian. 1987. Structure-function analysis of human interleukin-2. Identification of amino acid residues required for biological activity. J. Biol. Chem. 262:5723-5731.
25. Karp, C. L., S. H. El-Safi, T. A. Wynn, M. M. H. Satti, A. M. Korofani, M. Hag-Ali, F. A. Neva, T. B. Nutman, and D. L. Sacks. 1993. In vivo cytokine profiles in patients with Kala-azar: Marked elevation of both IL-10 and IFN-gamma. J. Clin. Invest. 91:1644-1648.
26. Kashima, N., C. Nishi-Takaoka, T. Fujita, S. Taki, and G. Yamada. 1985. Unique structure of murine interleukin 2 as deduced from cloned cDNAs. Nature 313:402-404.
27. Kaye, P. M., A. J. Curry, and J. M. Blackwell. 1991. Differential production of Th1- and Th2 derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146:2763-2770.
28. Konecki, D. S., J. Brennand, J. C. Fuscoe, C. T. Caskey, and A. C. Chinault. 1982. Hypoxanthine-guanine phosphoribosyltransferase genes of mouse and Chinese hamster: construction and sequence analysis of cDNA recombinants. Nucleic Acids Res. 10:6763-6775.
29. Lundell, D., C. Lunn, D. Dalgarno, J. Fossetta, R. Greenberg, R. Reim, M. Grace, and S. Narula. 1991. The carboxyl-terminal region of human interferon γ is important for biological activity: mutagenic and NMR analysis. Prot. Eng. 4:335-343.
30. Lundell, D., C. A. Lunn, M. M. Senior, P. J. Zavodny, and S. K. Narula. 1994. Importance of the loop connecting A and B helices of human interferon-γ in recognition by interferon-γ receptor. J. Biol. Chem. 269:16159-16162.
31. Mai, Z., K. G. Kousoulas, D. W. Horohov, and T. R. Klei. 1994. Cross-species PCR cloning of gerbil (Meriones unguiculatus) interleukin-2 cDNA and its expression in COS-7 cells. Vet. Immunol. Immunopathol. 40:63-71.
32. Masters, D. B., C. T. Griggs, and C. B. Berde. 1992. High sensitivity quantification of RNA from gels and autoradiograms with affordable optical scanning. Biotechniques 12:902-911.
33. McKnight, A. J., D. W. Mason, and A. N. Barclay. 1989. Sequence of rat interleukin 2 and anomalous binding of a mouse interleukin 2 cDNA probe to rat MHC class II-associated invariant chain mRNA. Immunogenetics 30:145-147.
34. McKnight, A. J., A. N. Barclay, and D. VV. Mason. 1991. Molecular cloning of rat interleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4+ T cells. Eur. J. Immunol. 21:1187-1194.
35. Melby, P. C., B. J. Darnell, and V. V. Tryon. 1993. Quantitative measurement of human cytokine gene expression by polymerase chain reaction. J. Immunol. Methods 159:235-244.
36. Melby, P. C., Y.-Z. Yang, J. Cheng, and W. Zhao. 1998. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani. Infect. Immun. 66:18-27.
37. + T cell clones. Arch. Med. Res. 27:473-479.
38. Miralles, G. D., M. Y. Stoeckle, D. F. McDermott, F. D. Finkelman, and H. W. Murray. 1994. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect. Immun. 62:1058-1063.
39. Moore, K. W., P. Vieira, D. F. Fioentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to Epstein-Barr virus gene BCRFI. Science 248:1230-1233.
40. Murphy, P. M. 1993. Molecular mimicry and generation of host defense protein diversity. Cell 72:823-826.
41. Narachi, M. A., J. A. Davis, Y.-R. Hsu, and T. Arakawa. 1987. Role of single disulfide in recombinant human tumor necrosis factor-α. J. Biol. Chem. 262:13107-13110.
42. Otsuko, T., D. Villaret, T. Yokotu, Y. Takebe, F. Lee, N. Arai, and K. Arai. 1987. Structural analysis of the mouse chromosomal gene encoding interleukin 4 which expresses B cell, T cell, and mast cell stimulating activities. Nucleic Acids Res. 15:333-344.
43. Pearson, R. D., G. Cox, T. Evans, D. L. Smith, D. Weidel, and J. Castracane. 1990. Wasting and macrophage production of tumor necrosis factor/cachectin and interleukin 1 in experimental visceral leishmaniasis. Am. J. Trop. Med. Hyg. 43:640-649.
44. Pennica, D., G. E. Nedwin, J. S. Hayflick, P. H. Seeburg, R. Derynck, M. A. Palladino, W. J. Kohr, B. B. Aggarwal, and D. V. Gueddel. 1984. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312:724-729.
45. Pennica, D., J. S. Hayflick, T. S. Bringman, M. A. Palladino, and D. V. Goeddel. 1985. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc. Natl. Acad. Sci. USA 82:6060-6064.
46. Qian, S. W., P. Kondaiah, A. B. Roberts, and M. Sporn. 1990. cDNA cloning by PCR of rat transforming growth factor β-1. Nucleic Acids Res. 18:3059.
47. Robb, R. J., R. M. Kutny, and V. Chowdhry. 1983. Purification and partial sequence analysis of human T-cell growth factor. Proc. Natl. Acad. Sci. USA 80:5990-5994.
48. Scharton-Kerston, T., L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5331-5330.
49. Schoenhaut, D. S., A. O. Chua, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, M. K. Gately, and U. Gubler. 1992. Cloning and expression of murine IL-12. J. Immunol. 148:3433-3440.
50. Squires, K. E., R. D. Schreiber, M. J. McElrath, B. Y. Rubin, S. L. Anderson, and H. W. Murray. 1989. Experimental visceral leishmaniasis: role of endogenous IFN-γ in host defense and tissue granulomatous response. J. Immunol. 143:4244-4249.
51. Stauber, L. A. 1958. Host resistance to the Khartoum strain of Leishmania donovani. Rice Inst. Pamph. 45:80.
52. Szente, B. E., I. J. Weiner, M. J. Jablonsky, N. R. Krishna, B. A. Torres, and H. M. Johnson. 1996. Structural requirements for agonist activity of a murine interferon-γ peptide. J. Interferon Cytokine Res. 16:813-817.
53. Taniguchi, T., H. Matsui, T. Fujita, C. Takaoka, N. Kashima, R. Yoshimoto, and J. Hamuro. 1983. Structure and expression of a cloned cDNA for human interleukin-2. Nature 302:305-310.
54. Theodos, C. M., L. Povinelli, R. Molina, B. Sherry, and R. Titus. 1991. Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo. Infect. Immun. 59:2839-2842.
55. Tumang, M. C. T., C. Keogh, L. L. Moldawer, D. C. Helfgott, R. Teitelbaum, J. Hariprashad, and H. W. Murray. 1994. Role and effect of TNF-α in experimental visceral leishmaniasis. J. Immunol. 153:768-775.
56. Vieira, P., R. de Waal-Malefyt, M.-N. Dang, K. E. Johnson, R. Kastelein, D. F. Fiorentino, J. E. deVries, M.-G. Roncarolo, T. R. Mosmann, and K. W. Moore. 1991. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA 88:1172-1176.
57. Vieth, M., A. Will, K. Schroppel, M. Rollinghoff, and A. Gessner. 1994. Interleukin 10 inhibits antimicrobial activity against Leishmania major in murine macrophages. Scand. J. Immunol. 40:403-409.
58. Wilson, M. E., M. Sandor, A. M. Blum, B. M. Young, A. Metwali, D. Elliott, R. G. Lynch, and J. V. Weinstock. 1996. Local suppression of IFN-γ in hepatie granulomas correlates with tissue-specific replication of Leishmania chagasi. J. Immunol. 156:2231-2239.
59. Windsor, W. T., R. Syto, A. Tsarbopoulos, R. Zhang, J. Durkin, S. Baldwin, S. Paliwal, P. W. Mui, B. Pramanik, P. P. Trotta, and S. H. Tindall. 1993. Disulfide bond assignments and secondary structure analysis of human and murine interleukin 10. Biochemistry 32:8807-8815.
60. Windsor, W. T., R. Syto, J. Durkin, P. Das, P. Reichert, B. Pramanik, S. Tindall, H. V. Le, J. Labdon, T. L. Nagabhushan, and P. P. Trotta. 1990. Disulfide bond assignment of mammalian cell-derived recombinant human interleukin 4. Biophys. J. 57:423A.
61. Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R. M. Hewick, K. Kelleher, S. H. Herrmann, S. C. Clark, L. Azzoni, S. H. Chan, G. Trinchieri, and B. Perussia. 1991. Cloning of cDNA for natural killer stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J. Immunol. 146: 3074-3081.
62. Yamamoto, R., A. Wang, C. R. Vitt, and L. S. Lin. 1989. Histidine 15: an important role in the cytotoxic activity of human tumor necrosis factor. Protein Eng. 7:553-558.
63. Yokota, T., T. Otsuka, T. Mosman, J. Banchereau, T. DeFrance, D. Blanchard, J. E. De Vries, F. Lee, and K.-I. Arai. 1986. Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. Proc. Natl. Acad. Sci. USA 83:5894-5898.